Levy Richard M

Avg. Two Year Performance

(61%) Avg. Purchase Return
(27%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return6%5%< 1%(45%)(61%)
Purchase Success Rate1 of 32 of 31 of 30 of 30 of 3
Average Sale Return----------
Sale Success Rate----------

SCOLR Pharma Inc.

Drugs » Diagnostic Substances

CFO & Exec. VP Finance:

Holdings: 27.6K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--